Teleneurology since 2018
There is nothing mild about an mTBI.
More than half of mild traumatic brain injuries are missed on first presentation. NeuroGlympse combines FDA-cleared ocular motor testing with continuous remote monitoring so the injury is found early — and followed until it resolves.
- mTBI diagnoses missed in the ED
- 56%
- Testing locations nationwide
- 50+
- Time to same-day testing
- 0 days
Start here
Three ways in, depending on who you are
Clinicians, attorneys and patients each need different things from the same clinical data. Pick your path.
Add neurology to your practice
Offer objective mTBI assessment and remote therapeutic monitoring without hiring a neurologist or retraining your staff.
I'm an attorneyObjective evidence for mTBI claims
FDA-cleared ocular motor testing, neurologist-authored reports and same-day appointments across 50+ locations. Letters of Protection accepted.
I'm a patientUnderstand your injury
Get your report reviewed by our care team, learn what the findings mean, and enroll in monitoring that tracks your recovery.
The diagnostic window
Eye movement is the key to objective diagnosis — and it does not last
Involuntary oculomotor changes after an mTBI are measurable, but they resolve. Testing within three weeks materially increases the probability of detecting them.
The typical timeline, without us
- Day 0Patient is injured
- Day 60Ocular motor motility improves — evidence fades
- Day 126+Patient is finally seen by a neurologist
By the time a specialist sees the patient, the most objective marker of injury has often normalised. The claim, and the care plan, lose their evidentiary anchor.
What an assessment measures
Ocular motor testing scores three domains. Normal and abnormal patterns are clearly separable:
| Domain | Normal | Abnormal |
|---|---|---|
| Pursuits | 88 | 19 |
| Saccades | 79 | 5 |
| Fixations | 97 | 26 |
Illustrative scores. Every report is interpreted by a board-certified neurologist rather than scored automatically.
Why it matters
A concussion rarely arrives alone
Post-mTBI comorbidity is the rule, not the exception — which is why a single point-in-time scan is not enough.
30–90%
Headaches — report headaches, especially early after injury
20–50%
Depression — develop depression within the first year
15–50%
Anxiety — develop an anxiety disorder
10–30%
PTSD — may develop PTSD
Prevalence ranges reflect the spread across the published literature. We present them as ranges deliberately; a single figure would imply more precision than the evidence supports.
The platform
Diagnosis is the beginning, not the deliverable
Remote therapeutic monitoring turns a one-off report into a longitudinal picture of how the injury actually evolves.
See the whole picture
Better care from home
Care team review

Clinical leadership
Reports are read by neurologists, not algorithms
Ann Conn, MD
Chief Medical Officer & Co-Founder
Fellowship-trained and triple board certified in Neurology, Pain Management and Headache Medicine, with 16 years of experience in interventional pain. Dr. Conn holds a BS in Chemical Engineering, attended medical school at LSU in New Orleans, trained in Neurology at Charity Hospital, and completed her fellowship at LSU. She is a 2020 graduate of the Harvard Medical School Media and Medicine program and serves as President of the Louisiana Society of Interventional Pain Physicians.
We recommend testing anyone with symptoms
Same-day telemedicine appointments, 50+ locations, and a report your care team can actually act on.
